A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alain Mita, MD
Cedars-Sinai Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Illinois Cancer Specialists
Niles, Illinois, United States
- Investigative Clinical Research of Indiana, Llc
Indianapolis, Indiana, United States
- Advanced Oncology Associates
Armonk, New York, United States
- Signal Point Clinical Research Center, Llc
Middletown, Ohio, United States
- Medical Oncology Associates of Wyoming Valley
Kingston, Pennsylvania, United States
- Texas Oncology - Arlington South
Arlington, Texas, United States
- Texas Oncology - Bedford
Bedford, Texas, United States
- Texas Oncology - Denton South
Denton, Texas, United States
- Texas Oncology - Fort Worth
Fort Worth, Texas, United States
- Texas Oncology - Garland
Garland, Texas, United States
- Texas Oncology - Lewisville
Lewisville, Texas, United States
- Cancer Care Centers of South Texas
San Antonio, Texas, United States
- Cancer Therapy & Research Center at Uthscsa
San Antonio, Texas, United States
- Texas Oncology - Tyler
Tyler, Texas, United States
- Lynchburg Hematology Oncology Clinic
Lynchburg, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 30 Sept 2013
- Completion
- 31 Aug 2015
- Last update posted
- 31 Mar 2016
- Registered enrollment
- 32
- Registry id
- NCT00998192
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.